Aptus Pharma will debut on the BSE SME platform on September 30. Its initial public offering closed with high investor participation. The IPO was subscribed over 22 times across categories. Retail and high net worth individuals showed significant demand. The company distributes pharmaceutical formulations. It reported revenue and profit growth. Proceeds will fund working capital and new office infrastructure.